BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 18230189)

  • 21. Arsenic trioxide sensitizes cancer stem cells to chemoradiotherapy. A new approach in the treatment of inoperable glioblastoma multiforme.
    Tomuleasa C; Soritau O; Kacso G; Fischer-Fodor E; Cocis A; Ioani H; Timis T; Petrescu M; Cernea D; Virag P; Irimie A; Florian IS
    J BUON; 2010; 15(4):758-62. PubMed ID: 21229642
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High density is a property of slow-cycling and treatment-resistant human glioblastoma cells.
    Sabelström H; Quigley DA; Fenster T; Foster DJ; Fuchshuber CAM; Saxena S; Yuan E; Li N; Paterno F; Phillips JJ; James CD; Norling B; Berger MS; Persson AI
    Exp Cell Res; 2019 May; 378(1):76-86. PubMed ID: 30844389
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression of CD133 and CD44 in glioblastoma stem cells correlates with cell proliferation, phenotype stability and intra-tumor heterogeneity.
    Brown DV; Filiz G; Daniel PM; Hollande F; Dworkin S; Amiridis S; Kountouri N; Ng W; Morokoff AP; Mantamadiotis T
    PLoS One; 2017; 12(2):e0172791. PubMed ID: 28241049
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ionizing radiations sustain glioblastoma cell dedifferentiation to a stem-like phenotype through survivin: possible involvement in radioresistance.
    Dahan P; Martinez Gala J; Delmas C; Monferran S; Malric L; Zentkowski D; Lubrano V; Toulas C; Cohen-Jonathan Moyal E; Lemarie A
    Cell Death Dis; 2014 Nov; 5(11):e1543. PubMed ID: 25429620
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Estimation of the effectiveness ratio (α/β) for resistant cancer cells in U87MG human glioblastoma.
    Marmolejo-León P; Azorín-Vega EP; Jiménez-Mancilla N; Mendoza-Nava HJ; Mitsoura E; Pineda B; Torres-García E
    Appl Radiat Isot; 2018 Nov; 141():156-161. PubMed ID: 29452949
    [TBL] [Abstract][Full Text] [Related]  

  • 26. BRM270, a Compound from Natural Plant Extracts, Inhibits Glioblastoma Stem Cell Properties and Glioblastoma Recurrence.
    Jeon HY; Park CG; Ham SW; Choi SH; Lee SY; Kim JY; Seo S; Jin X; Kim JK; Eun K; Kim EJ; Kim H
    J Med Food; 2017 Sep; 20(9):838-845. PubMed ID: 28792781
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HDAC4 and HDAC6 sustain DNA double strand break repair and stem-like phenotype by promoting radioresistance in glioblastoma cells.
    Marampon F; Megiorni F; Camero S; Crescioli C; McDowell HP; Sferra R; Vetuschi A; Pompili S; Ventura L; De Felice F; Tombolini V; Dominici C; Maggio R; Festuccia C; Gravina GL
    Cancer Lett; 2017 Jul; 397():1-11. PubMed ID: 28342984
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Polo‑like kinase 4 promotes tumorigenesis and induces resistance to radiotherapy in glioblastoma.
    Wang J; Zuo J; Wang M; Ma X; Gao K; Bai X; Wang N; Xie W; Liu H
    Oncol Rep; 2019 Apr; 41(4):2159-2167. PubMed ID: 30816483
    [TBL] [Abstract][Full Text] [Related]  

  • 29. HJURP knockdown disrupts clonogenic capacity and increases radiation-induced cell death of glioblastoma cells.
    Serafim RB; Cardoso C; Di Cristofaro LFM; Pienna Soares C; Araújo Silva W; Espreafico EM; Paçó-Larson ML; Price BD; Valente V
    Cancer Gene Ther; 2020 May; 27(5):319-329. PubMed ID: 31138900
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Compensatory cross-talk between autophagy and glycolysis regulates senescence and stemness in heterogeneous glioblastoma tumor subpopulations.
    Martell E; Kuzmychova H; Senthil H; Kaul E; Chokshi CR; Venugopal C; Anderson CM; Singh SK; Sharif T
    Acta Neuropathol Commun; 2023 Jul; 11(1):110. PubMed ID: 37420311
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Induction of autophagy promotes differentiation of glioma-initiating cells and their radiosensitivity.
    Zhuang W; Li B; Long L; Chen L; Huang Q; Liang Z
    Int J Cancer; 2011 Dec; 129(11):2720-31. PubMed ID: 21384342
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CXCR4 increases in-vivo glioma perivascular invasion, and reduces radiation induced apoptosis: A genetic knockdown study.
    Yadav VN; Zamler D; Baker GJ; Kadiyala P; Erdreich-Epstein A; DeCarvalho AC; Mikkelsen T; Castro MG; Lowenstein PR
    Oncotarget; 2016 Dec; 7(50):83701-83719. PubMed ID: 27863376
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treating Glioblastoma Multiforme (GBM) with super hyperfractionated radiation therapy: Implication of temporal dose fractionation optimization including cancer stem cell dynamics.
    Yu VY; Nguyen D; O'Connor D; Ruan D; Kaprealian T; Chin R; Sheng K
    PLoS One; 2021; 16(2):e0245676. PubMed ID: 33524046
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of cancer stem cell-like properties and reduced chemoradioresistance of glioblastoma using microRNA145 with cationic polyurethane-short branch PEI.
    Yang YP; Chien Y; Chiou GY; Cherng JY; Wang ML; Lo WL; Chang YL; Huang PI; Chen YW; Shih YH; Chen MT; Chiou SH
    Biomaterials; 2012 Feb; 33(5):1462-76. PubMed ID: 22098779
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ionizing radiation induces endothelial transdifferentiation of glioblastoma stem-like cells through the Tie2 signaling pathway.
    Deshors P; Toulas C; Arnauduc F; Malric L; Siegfried A; Nicaise Y; Lemarié A; Larrieu D; Tosolini M; Cohen-Jonathan Moyal E; Courtade-Saidi M; Evrard SM
    Cell Death Dis; 2019 Oct; 10(11):816. PubMed ID: 31659157
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of the STAT3 inhibitor STX-0119 on the proliferation of cancer stem-like cells derived from recurrent glioblastoma.
    Ashizawa T; Miyata H; Iizuka A; Komiyama M; Oshita C; Kume A; Nogami M; Yagoto M; Ito I; Oishi T; Watanabe R; Mitsuya K; Matsuno K; Furuya T; Okawara T; Otsuka M; Ogo N; Asai A; Nakasu Y; Yamaguchi K; Akiyama Y
    Int J Oncol; 2013 Jul; 43(1):219-27. PubMed ID: 23612755
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MicroRNAs as regulators of neural stem cell-related pathways in glioblastoma multiforme.
    González-Gómez P; Sánchez P; Mira H
    Mol Neurobiol; 2011 Dec; 44(3):235-49. PubMed ID: 21728042
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Marker-independent method for isolating slow-dividing cancer stem cells in human glioblastoma.
    Richichi C; Brescia P; Alberizzi V; Fornasari L; Pelicci G
    Neoplasia; 2013 Jul; 15(7):840-7. PubMed ID: 23814495
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tropism of mesenchymal stem cell toward CD133
    Pavon LF; Sibov TT; de Souza AV; da Cruz EF; Malheiros SMF; Cabral FR; de Souza JG; Boufleur P; de Oliveira DM; de Toledo SRC; Marti LC; Malheiros JM; Paiva FF; Tannús A; de Oliveira SM; Chudzinski-Tavassi AM; de Paiva Neto MA; Cavalheiro S
    Stem Cell Res Ther; 2018 Nov; 9(1):310. PubMed ID: 30413179
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of notch signaling in glioblastoma targets cancer stem cells via an endothelial cell intermediate.
    Hovinga KE; Shimizu F; Wang R; Panagiotakos G; Van Der Heijden M; Moayedpardazi H; Correia AS; Soulet D; Major T; Menon J; Tabar V
    Stem Cells; 2010 Jun; 28(6):1019-29. PubMed ID: 20506127
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.